Therapy News and Research

RSS

PSA failure linked to increased risk of death among healthy men

A new study by investigators at Brigham and Women's Hospital has found that a rise in prostate-specific antigen (PSA) levels in healthy men who have previously been treated for prostate cancer is significantly associated with a 1.6-fold increased risk of death.

6 Sep 2016

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University, the Atlanta Veterans Affairs Medical Center and Wenzhou Medical University and Southwest University in China.

6 Sep 2016

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Two studies appearing in the September 6 issue of JAMA examine the effectiveness of nasal sprays to reduce the frequency and duration of nosebleeds caused by hereditary hemorrhagic telangiectasia (HHT), an inherited condition characterized by abnormal blood vessels which are delicate and prone to bleeding.

6 Sep 2016

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

Philips Respironics, a division of Royal Philips, will showcase its portfolio of connected sleep and respiratory solutions at the European Respiratory Society (ERS) International Congress 2016 in London (September 3-7).

6 Sep 2016

New software that simulates interventions could spare young heart patients from surgery

Children with congenital heart defects often undergo a battery of strenuous examinations and interventions. In the EU CARDIOPROOF project, Fraunhofer researchers have developed software to simulate certain interventions in advance.

6 Sep 2016

New Focused Update to CCS atrial fibrillation guidelines released

The Canadian Journal of Cardiology has just released the 2016 Focused Update to the Canadian Cardiovascular Society's atrial fibrillation (AF) guidelines.

6 Sep 2016

Enzyme from oral bacteria could be potential therapy for celiac disease

Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease (CD), an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten.

6 Sep 2016

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

A team of scientists led by Dr Bhaskar Bhattacharya and Associate Professor Richie Soong from the Cancer Science Institute of Singapore at the National University of Singapore conducted a study on acquired resistance (AQR) to combination drug treatment in cancer and found that the mechanisms of AQR for the combination drugs were different from that of the individual drugs.

6 Sep 2016

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.

6 Sep 2016

HIF-2 inhibitors could be promising target to combat kidney cancer

A new class of drugs called HIF-2 inhibitors is more effective and better tolerated than the standard of care drug sunitinib in treating kidney cancer, researchers with the Kidney Cancer Program at Harold C. Simmons Comprehensive Cancer Center have found.

6 Sep 2016

Novel technique offers new insights into growth variation across single cells

A new technique invented at MIT can precisely measure the growth of many individual cells simultaneously.

5 Sep 2016

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA, European Union and, though to a smaller degree, in Japan by 2020, according to new research published in the leading cancer journal Annals of Oncology today (Tuesday).

5 Sep 2016

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

The loss of CHD1, one of the most frequently mutated genes in prostate tumors, sensitizes human prostate cancer cells to different drugs, including PARP inhibitors.

5 Sep 2016

Philips unveils new products for healthy lifestyle at IFA 2016

At this year’s Internationale Funkausstellung in Berlin, Germany, Royal Philips today announced a range of new products that empower consumers to stay healthy, live well and enjoy life.

2 Sep 2016

Breakthrough research on radioactive element could lead to new weapon against cancer

A new weapon against cancer could be just around the corner now that a Cal Poly Pomona professor and her colleagues from Stanford, Cornell and Los Alamos National Laboratory have unlocked some of the secrets of a fickle radioactive element.

2 Sep 2016

Implanted nerve stimulator shows promise in treating central sleep apnea patients

Results from an international, randomized study show that an implanted nerve stimulator significantly improves symptoms in those with central sleep apnea, without causing serious side effects.

2 Sep 2016

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

The National Institutes of Health will fund six projects to identify biological factors that affect neural regeneration in the retina.

2 Sep 2016

Complementary health approaches appear to be effective in helping manage pain

Data from a review of U.S.-based clinical trials published today in Mayo Clinic Proceedings suggest that some of the most popular complementary health approaches--such as yoga, tai chi, and acupuncture--appear to be effective tools for helping to manage common pain conditions.

1 Sep 2016

Sign language may be highly effective in treating children with apraxia of speech

Using sign language with intensive speech therapy may be an effective treatment for children with a rare speech disorder called apraxia of speech, according to Penn State College of Medicine researchers.

1 Sep 2016

Added benefit not proven for new combination therapy in multiple myeloma

The monoclonal antibody elotuzumab has been approved in combination with lenalidomide and dexamethasone since May 2016 for further treatment of multiple myeloma in adults who have received at least one previous treatment.

1 Sep 2016

Therapy News and Research

PSA failure linked to increased risk of death among healthy men

Edible ginger-derived nano-lipids could effectively deliver drugs for treating colon cancer

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Philips to highlight connected sleep and respiratory product portfolio at ERS International Congress 2016

New software that simulates interventions could spare young heart patients from surgery

New Focused Update to CCS atrial fibrillation guidelines released

Enzyme from oral bacteria could be potential therapy for celiac disease

NUS study could contribute to reducing acquired resistance to combination drug treatment in cancer

Overweight kidney cancer patients live longer than normal-weight counterparts, study shows

HIF-2 inhibitors could be promising target to combat kidney cancer

Novel technique offers new insights into growth variation across single cells

Oral contraceptive use may be reason for decline in mortality from ovarian cancer worldwide

DNA-binding protein CHD1 could be potential biomarker for targeted prostate cancer treatment

Philips unveils new products for healthy lifestyle at IFA 2016

Breakthrough research on radioactive element could lead to new weapon against cancer

Implanted nerve stimulator shows promise in treating central sleep apnea patients

Six NIH-funded projects aim to identify biological factors that affect neural regeneration

Complementary health approaches appear to be effective in helping manage pain

Sign language may be highly effective in treating children with apraxia of speech

Added benefit not proven for new combination therapy in multiple myeloma

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News